Equities

Bactiguard Holding AB

Bactiguard Holding AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)37.00
  • Today's Change0.20 / 0.54%
  • Shares traded1.13k
  • 1 Year change-38.33%
  • Beta-0.0916
Data delayed at least 15 minutes, as of Nov 08 2024 17:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Bactiguard Holding AB's revenues fell -11.96% from 253.50m to 223.17m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from a loss of 52.88m to a larger loss of 138.38m.
Gross margin47.53%
Net profit margin-22.01%
Operating margin-19.39%
Return on assets-8.16%
Return on equity-15.76%
Return on investment-11.32%
More ▼

Cash flow in SEKView more

In 2023, cash reserves at Bactiguard Holding AB fell by 74.51m. Cash Flow from Investing was negative at 8.61m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 52.33m for operations while cash used for financing totalled 11.84m.
Cash flow per share-0.0395
Price/Cash flow per share--
Book value per share9.37
Tangible book value per share-0.3118
More ▼

Balance sheet in SEKView more

Bactiguard Holding AB has a Debt to Total Capital ratio of 41.75%, a lower figure than the previous year's 58.41%.
Current ratio0.6836
Quick ratio0.5898
Total debt/total equity0.7168
Total debt/total capital0.4175
More ▼

Growth rates in SEK

Year on year, growth in earnings per share excluding extraordinary items dropped -161.71%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
55.23
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.